MiRNA diagnostic biomarkers for diffuse alveolar dysfunction type drug interstitial pneumonia

摘要

Development of miRNA biomarkers for diagnosis of diffuse alveolar damage (DAD) and diagnosis of diffuse alveolar damage (DAD) and other types of interstitial pneumonia (OP) with different therapeutic responses to dads and pulmonary diseases other than interstitial pneumonia.A method for examining diffuse alveolar injury, including measuring the expression in a sample derived from a subject, of at least one miRNA selected from the group consisting of hsa-mir-10a-5p, hsa-mir-340-5 and hsa-mir-150-5p.Diagram